Wednesday, October 24, 2018

An International Summit in Human Genetics and Genomics- Aug 28th - Sept. 28th, 2019

Summit date- August 28 - September 28, 2019 
Application deadline- December 2010 ,2018
Eligibility- healthcare professionals and trainees from developing nations that are in their early-mid careers

The Human Genome Project (HGP), led by the National Human Genome Research Institute (NHGRI) at NIH, was the world's largest, government sponsored, collaborative, biological project that led to the development of a reference sequence for the human genome. This effort benefitted both medical research and the practice of medicine worldwide, as it provided new insights into the genetic contributions to disease.
Many scientists and consortia are now working on collecting data on variations in human genes and their association with disease (e.g. Human Variome Project, UNESCO, ClinVar, ExAC etc.). It is anticipated that these efforts will help find new, improved and cost-effective approaches for the diagnosis, treatment and prevention of disease, thereby reducing the burden of disease and disability, and alleviating the economic stress attributed by these conditions on the world's most vulnerable populations.
This Summit is a 5-year initiative (2016-2020) designed to help developing nations build and expand their knowledge base, infrastructure, systems, research efforts and technologies in human genetics and genomics. Increasing their access to these resources will help them build capacity in these areas and will help resource-poor countries address their public health challenges in genetic diseases. This will ultimately help build healthier nations worldwide.

Eligibility and Application

The program is intended to train healthcare professionals and trainees from developing nations that are in their early-mid careers. The curriculum is designed in English for healthcare professionals with an advanced understanding of the biological sciences. Hence, research scientists (Ph.D.), physicians (M.B.B.S./M.D.), dentists (D.D.S./D.M.D.), dentist-scientists, nurses (M.S./Ph.D.), counselors (M.S./Ph.D.) and medical, dental and graduate school trainees can apply. Selected candidates will be fully sponsored (travel, local transportation in the United States, lodging and per diem) for the duration of the summit (Aug 28th - Sept. 28th, 2019). Participants will share lodging quarters with another participant (same sex) to reduce costs. Attendance on all days and of all events is required. Self-sponsorship may be possible, provided seats are available.

In order to measure the success of this program, candidates will be required to participate in:
  • A pre- and post-survey to each day's curriculum and at the end of the Summit.
  • An intermediate report (1-2 years, as determined) on their professional development and career choices and advancements in genomics.
  • Follow-up reports every year to measure their ability to successfully integrate their learning in research and practice, by:
    • The number of collaborations established and publications.
    • Systems established to record, track and monitor the occurrence and re-occurrence of congenital birth defects and genetic diseases.
    • Number of cases identified, diagnosed and treated.
    • Number of cases referred for counseling and for medical management of the condition.
    • Improvement in the quality of life of affected individuals and their families.
    • The multiplier effect resulting from their return to their countries to build capacity (train others, set up research/clinical facilities, introduce genomics in the curriculum etc.) and strengthen their curricula, research and healthcare systems.
Interested and qualified candidates must apply on official letterhead and signatures, with:
  1. Resume/ Curriculum Vitae
  2. Cover letter, not to exceed 2 pages indicating-
  • Their interest in attending the Summit.
  • Specification of the area in which 'tailored' training is desired, based on interests and needs.
  • The impact the Summit will have on their careers, in Genetics and Genomics.
  • Plans to implement the knowledge gained to address the public health challenges specific to their nation.
  • Their ability and commitment for continued evaluation over a 5-year period.
  1. Three letters of recommendation on official letterhead signed by-
  • Immediate supervisor
  • Head/Chair of the Department
  • Dean of Institution
  • Vice Chancellor of the University
  • Employer
  • Professors for trainees currently in medical or graduate school

How to Apply:

We are now accepting applications for the 2019 Summit. A 'complete' application package must be submitted via email to mkaur@mail.nih.gov  by December 10, 2018. Selections are on a rolling basis and seats are limited so please apply early. Incomplete applications will not be considered.

Thursday, October 18, 2018

U.S.-JAPAN COOPERATIVE MEDICAL SCIENCES PROGRAM COLLABORATIVE AWARDS -CRDF GLOBAL

CRDF Global is accepting proposals from joint U.S., Japan, and other regional Asia-Pacific (APac) based investigators working in the field of infectious disease and immunology research for the U.S.-Japan Cooperative Medical Sciences Program (USJCMSP) Collaborative Awards, 2019. This initiative is jointly funded by CRDF Global utilizing funds provided by the U.S. National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) and the Japan Agency for Medical Research and Development (AMED). USJCMSP Collaborative Awards, 2019 is the third round of a collaborative award program that was initiated in 2016 following the 50th anniversary celebration of the USJCMSP. The awards program aims to promote the inclusion of early-stage and female scientists in collaborative research.

Proposal Deadline: Saturday, December 15, 2018

ELIGIBILITY

Individuals who served as PIs on the 2016 or 2018 USJCMSP collaborative awards cannot apply as PIs in this competition.

All proposals must meet each of the following eligibility criteria:

1) Each proposal must include one PI from each sub-team (U.S., Japan and/or APac team) who will serve together as Co-PIs of the collaborative team. Co-PIs will share overall responsibility for the project and coordinating all project participants and institutions. The institution at which each PI is employed will serve as the individual team’s Principal Institution[1] designated on the proposal. Additional Investigators and institutions may be included as secondary collaborators to each individual team at the discretion of the co-PIs.

2) Each PI must:
  • Possess the degree of Ph.D., M.D., or the equivalent research experience 
  • Demonstrate scientific capacity and research experience. 
  • Be employed at an institution that can serve as the Principal Institution on the award. 
3) On each application it is strongly encouraged that both of the Japanese sub-team and the U.S. sub-team include as a PI an early-stage or female investigator. At least either of the Japanese sub-team or the U.S. sub-team must include an early-stage or female investigator as a PI. In applications that include a collaborating APac sub-team, the APac sub-team must include at least ONE early-stage or female investigator, preferably as the APac sub-team PI. If senior investigators (i.e., non-early-stage) are included as members of the proposed Japanese, U.S. or APac sub-teams, at least one senior investigator involved in each project must be identified as a mentor and trainer who will work with the early-stage investigator(s) involved in each project.

4) Sub-team budget allocation percentages must total 100% for the collaborative team and may not exceed $60,000 USD.

Investigators from the United States, Japan, and other APac countries are invited to jointly apply for funding for collaborative research projects focused on the areas of research listed below and other related topics. Basic and clinical immunology and endemic and emerging infectious diseases relevant to the APac region eligible for this competition are the following:
  • Acute Respiratory Infections
  • Cholera and other Bacterial Enteric Diseases
  • Hepatitis
  • Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS)
  • Immunology related to Infections Diseases
  • Nutrition and Metabolism (related to Infectious Diseases and/or Immunology)
  • Parasitic Diseases
  • Resistance against Anti-Microbial/Viral Agents
  • Tuberculosis, Leprosy, and other Mycobacteria
  • Other Viral Diseases
  • Other Emerging and Reemerging Diseases
More information here: http://www.crdfglobal.org/funding-opportunities/2019-USJCMSP